The presence of Pbx1b in tissue sections was detected with an anti-Pbx1b antibody
21 using an ABC reagent (Vectastain), MOM, and DAB (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions.
For immunochemistry, the sections were blocked for 1 hour at room temperature (RT) in PBS, 2% NGS, and 0.2% Triton-X and incubated overnight at 4°C with the primary antibodies. The sections were washed three times for 5 minutes each at RT in PBS, and then incubated with secondary antibodies (1:2000 dilution) for 1 hour at RT. The slides were counterstained with DAPI, mounted with glycerol/PBS (AS1; Citifluor Ltd., London, UK), and photographed (BX51; Olympus, Tokyo, Japan). Primary antibodies consisted of anti-Notch1 (1:500; 15580-100; Abcam, Cambridge, UK), anti-Ki67 (1:500; 49990-100; Abcam), anti-decorin (1:10; R&D Systems, Minneapolis, MN), anti-Pax6 (1:100; Developmental Studies Hybridoma Bank, Iowa City, IA), anti-K12 (1:500; Santa Cruz Biotechnology, Santa Cruz, CA), anti-K10 (1:500; Santa Cruz), and anti-CD45 (1:300; Ebiosciences, San Diego, CA). Secondary antibodies consisted of anti-mouse (Alexa 488 and 494 [Invitrogen-Molecular Probes, Eugene, OR], A21121 and A1105 [Serotec, Oxford, UK] and anti-rabbit (Alexa 488 and 494; A11008 and A11012) antibodies.